KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Change in Account Payables (2016 - 2025)

Exact Sciences (EXAS) has disclosed Change in Account Payables for 16 consecutive years, with $48.9 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 825.36% to $48.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $214.0 million through Dec 2025, up 391.62% year-over-year, with the annual reading at $214.0 million for FY2025, 391.62% up from the prior year.
  • Change in Account Payables for Q4 2025 was $48.9 million at Exact Sciences, down from $67.1 million in the prior quarter.
  • The five-year high for Change in Account Payables was $105.5 million in Q4 2021, with the low at -$66.0 million in Q1 2022.
  • Average Change in Account Payables over 5 years is $22.9 million, with a median of $36.4 million recorded in 2022.
  • Peak annual rise in Change in Account Payables hit 2308.71% in 2024, while the deepest fall reached 1010.96% in 2024.
  • Over 5 years, Change in Account Payables stood at $105.5 million in 2021, then crashed by 64.83% to $37.1 million in 2022, then fell by 14.62% to $31.7 million in 2023, then crashed by 83.33% to $5.3 million in 2024, then skyrocketed by 825.36% to $48.9 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at $48.9 million, $67.1 million, and $39.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.